| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/01/2004 | CN1525962A De Rock Herman Augustinus |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1164580C Diazole derivatives as serotonergic agonist |
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 09/01/2004 | CN1164574C Phenoxypropylamine compounds |
| 08/31/2004 | US6784298 2-((3-cyclohexyl-2-(2,5-dioxo-4-(thiophen-2-yl)methylimida-zol idin-1-yl)propanoyl)amino) thiazole-4-carboxylic acid methyl ester, e.g.; antidiabetic agents; hypoglycemic agents; a glucose sensor in beta-cells and hepatocytes |
| 08/31/2004 | US6784292 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 08/31/2004 | US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP |
| 08/31/2004 | US6784199 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784192 Na+ channel inhibitory action is useful for therapy and prevention for example, arrhythmia, various neuralgias and analgesic |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784184 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| 08/31/2004 | US6784182 Serine protease inhibitors |
| 08/31/2004 | US6784180 Piperidines derivatives and their use as serotonin receptor antagonists |
| 08/31/2004 | US6784167 17-beta-hydroxysteroid dehydrogenase-II inhibitors |
| 08/31/2004 | US6784137 6-aryl-4-aminopicolinates and their use as herbicides |
| 08/26/2004 | WO2004072101A2 Phenylglycine derivatives useful as serine protease inhibitors |
| 08/26/2004 | WO2004072070A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 08/26/2004 | WO2004072069A1 Carboxamide derivatives |
| 08/26/2004 | WO2004072068A1 Vanilloid receptor ligands and their use in treatments |
| 08/26/2004 | WO2004072066A1 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/26/2004 | WO2004072052A2 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus |
| 08/26/2004 | WO2004072051A1 Isoxazole compounds as inhibitors of heat shock proteins |
| 08/26/2004 | WO2004072031A2 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004071447A2 Substituted azole derivatives as therapeutic agents |
| 08/26/2004 | WO2004071440A2 Thiazolyl-based compounds useful as kinase inhibitors |
| 08/26/2004 | WO2004058702A3 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity |
| 08/26/2004 | WO2004043354A3 Ophthalmic compositions for treating ocular hypertension |
| 08/26/2004 | WO2004029066A3 Bifunctional heterocyclic compounds and methods of making and using same |
| 08/26/2004 | WO2004018461A3 Antibacterial benzoic acid derivatives |
| 08/26/2004 | WO2004018438A3 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
| 08/26/2004 | US20040167334 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides |
| 08/26/2004 | US20040167333 For therapy of eosinophil-dependent inflammatory diseases |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167193 Fungicides |
| 08/26/2004 | US20040167187 Sulfhydantoins as phosphate isosteres |
| 08/26/2004 | US20040167182 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167135 Dihydropyrimidines |
| 08/26/2004 | US20040167123 Anti-infective agents |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040167116 Viricides |
| 08/26/2004 | US20040167083 Effector conjugates, methods for their preparation and their pharmaceutical use |
| 08/26/2004 | CA2516118A1 Substituted n-arylheterocycles, method for production and use thereof as medicaments |
| 08/26/2004 | CA2515728A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives |
| 08/26/2004 | CA2515670A1 Phenylacetamides and their use as glucokinase modulators |
| 08/26/2004 | CA2515215A1 Vanilloid receptor ligands and their use in treatments |
| 08/26/2004 | CA2514363A1 Substituted azole derivatives as therapeutic agents |
| 08/25/2004 | EP1449841A1 New fungicidal compounds |
| 08/25/2004 | EP1448559A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient |
| 08/25/2004 | EP1448558A1 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same |
| 08/25/2004 | EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
| 08/25/2004 | EP1448554A1 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases |
| 08/25/2004 | EP1448551A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/25/2004 | EP1448536A1 Cyclopropyl-containing oxazolidinone antibiotics and derivatives thereof |
| 08/25/2004 | EP1448531A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/25/2004 | EP1448526A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448198A1 Nicotin-or isonicotin benzothiazole derivatives |
| 08/25/2004 | EP1448196A1 Benzothiazole derivatives as adenosine receptor ligands |
| 08/25/2004 | EP1448187A2 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same |
| 08/25/2004 | EP1150977B1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| 08/25/2004 | EP1087963B1 Inhibitors of glycogen synthase kinase 3 |
| 08/25/2004 | EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524078A Antagonists of mcp-1 function and methods of use thereof |
| 08/25/2004 | CN1524077A Therapeutic chroman compounds |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523986A Substituted oxazolidinones for combinational therapy |
| 08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
| 08/25/2004 | CN1163496C Vinyl-pyrrolidone cynnematin with alkali subtituent |
| 08/25/2004 | CN1163491C 3-amino-2-mercapto benzoic acid derivative and its preparation method |
| 08/25/2004 | CN1163363C Optical recording media |
| 08/25/2004 | CN1163139C Agricultural and horticultural disease controller and method for controlling diseases |
| 08/24/2004 | US6780996 Process for the preparation of 7-substituted-3 quinolinecarbonitriles |
| 08/24/2004 | US6780992 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 08/24/2004 | US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780864 Piperazine and piperidine compounds |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780857 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/19/2004 | WO2004069832A2 Antibacterial agents |
| 08/19/2004 | WO2004069830A1 Triazole compounds and the therapeutic use thereof |
| 08/19/2004 | WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis |
| 08/19/2004 | WO2004069818A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004069226A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides |